$USPH
U S PHYSICAL THERAPY INC /NV

2019 Q4 Form 10-Q Financial Statement

#000114036119020161 Filed on November 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $122.1M $117.3M $113.1M
YoY Change 4.06% 3.65% 9.83%
Cost Of Revenue $95.10M $89.90M $87.10M
YoY Change 3.26% 3.21% 6.48%
Gross Profit $26.96M $27.37M $26.08M
YoY Change 6.9% 4.97% 23.0%
Gross Profit Margin 22.08% 23.34% 23.05%
Selling, General & Admin $11.70M $10.56M $10.64M
YoY Change 12.5% -0.82% 28.23%
% of Gross Profit 43.4% 38.56% 40.82%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.720M $2.420M $2.470M
YoY Change 12.4% -2.02% -0.4%
% of Gross Profit 10.09% 8.84% 9.47%
Operating Expenses $11.70M $10.56M $10.64M
YoY Change 11.43% -0.82% 28.23%
Operating Profit $15.29M $16.82M $15.43M
YoY Change 3.26% 8.96% 19.64%
Interest Expense -$800.0K $557.0K $579.0K
YoY Change 166.67% -3.8% -118.09%
% of Operating Profit -5.23% 3.31% 3.75%
Other Income/Expense, Net
YoY Change
Pretax Income $14.40M $16.27M $14.87M
YoY Change -11.66% 9.39% 53.3%
Income Tax $2.400M $3.197M $2.991M
% Of Pretax Income 16.67% 19.65% 20.11%
Net Earnings $7.900M $9.047M $8.102M
YoY Change -24.04% 11.66% 55.81%
Net Earnings / Revenue 6.47% 7.72% 7.16%
Basic Earnings Per Share
Diluted Earnings Per Share $617.2K $703.1K $637.8K
COMMON SHARES
Basic Shares Outstanding 12.77M 12.77M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.50M $27.90M $32.20M
YoY Change 0.43% -13.35% 85.06%
Cash & Equivalents $23.55M $27.86M $32.24M
Short-Term Investments
Other Short-Term Assets $5.787M $7.098M $4.900M
YoY Change 32.94% 44.86% -9.26%
Inventory
Prepaid Expenses
Receivables $46.23M $47.12M $53.50M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $85.39M $92.53M $90.70M
YoY Change 7.79% 2.02% 23.57%
LONG-TERM ASSETS
Property, Plant & Equipment $22.09M $21.37M $20.00M
YoY Change 9.52% 6.86% -3.85%
Goodwill $317.7M $316.6M
YoY Change 8.23%
Intangibles $52.59M $53.39M
YoY Change 7.7%
Long-Term Investments
YoY Change
Other Assets $1.519M $1.470M $1.400M
YoY Change 6.22% 5.0% 16.67%
Total Long-Term Assets $545.1M $468.3M $364.3M
YoY Change 49.78% 28.55% 7.91%
TOTAL ASSETS
Total Short-Term Assets $85.39M $92.53M $90.70M
Total Long-Term Assets $545.1M $468.3M $364.3M
Total Assets $630.5M $560.8M $455.0M
YoY Change 42.27% 23.26% 10.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.500M $2.900M $2.100M
YoY Change 25.0% 38.1% 16.67%
Accrued Expenses $30.86M $33.57M $40.10M
YoY Change -19.84% -16.28% 27.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $728.0K $718.0K $4.800M
YoY Change -49.23% -85.04% 77.78%
Total Short-Term Liabilities $60.56M $62.80M $47.00M
YoY Change 44.38% 33.61% 30.56%
LONG-TERM LIABILITIES
Long-Term Debt $50.36M $55.29M $54.70M
YoY Change 31.14% 1.08% -8.83%
Other Long-Term Liabilities $141.0K $718.0K $2.700M
YoY Change -82.99% -73.41% 0.0%
Total Long-Term Liabilities $50.50M $56.01M $57.40M
YoY Change 28.73% -2.42% -8.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $60.56M $62.80M $47.00M
Total Long-Term Liabilities $50.50M $56.01M $57.40M
Total Liabilities $181.4M $188.1M $243.1M
YoY Change 96.42% -22.64% 14.4%
SHAREHOLDERS EQUITY
Retained Earnings $184.4M $181.1M
YoY Change 10.13%
Common Stock $150.0K $150.0K
YoY Change 0.67%
Preferred Stock
YoY Change
Treasury Stock (at cost) $31.63M $31.63M
YoY Change 0.0%
Treasury Stock Shares $2.215M $2.215M
Shareholders Equity $240.3M $235.5M $211.9M
YoY Change
Total Liabilities & Shareholders Equity $560.8M $565.2M $455.0M
YoY Change 26.55% 24.22% 10.71%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income $7.900M $9.047M $8.102M
YoY Change -24.04% 11.66% 55.81%
Depreciation, Depletion And Amortization $2.720M $2.420M $2.470M
YoY Change 12.4% -2.02% -0.4%
Cash From Operating Activities $15.99M $17.84M $23.39M
YoY Change -15.84% -23.73% 25.48%
INVESTING ACTIVITIES
Capital Expenditures -$2.760M -$2.550M -$2.040M
YoY Change 46.81% 25.0% -12.45%
Acquisitions
YoY Change
Other Investing Activities -$3.260M -$4.170M -$7.210M
YoY Change 2073.33% -42.16% 10200.0%
Cash From Investing Activities -$6.020M -$6.730M -$9.250M
YoY Change 196.55% -27.24% 285.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -14.27M -18.12M -9.050M
YoY Change -44.78% 100.22% -52.52%
NET CHANGE
Cash From Operating Activities 15.99M 17.84M 23.39M
Cash From Investing Activities -6.020M -6.730M -9.250M
Cash From Financing Activities -14.27M -18.12M -9.050M
Net Change In Cash -4.300M -7.010M 5.090M
YoY Change -51.52% -237.72% -280.5%
FREE CASH FLOW
Cash From Operating Activities $15.99M $17.84M $23.39M
Capital Expenditures -$2.760M -$2.550M -$2.040M
Free Cash Flow $18.75M $20.39M $25.43M
YoY Change -10.2% -19.82% 21.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 us-gaap Profit Loss
ProfitLoss
13069000
CY2019Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2863000
CY2018Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
6742000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
U S PHYSICAL THERAPY INC /NV
dei Entity Central Index Key
EntityCentralIndexKey
0000885978
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12774157
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
false
CY2018Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2019000
CY2019Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
10462000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44751000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
47118000
CY2018Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
3124000
CY2019Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
2996000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38493000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5262000
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33573000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
64154000
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
65040000
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
85828000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
80028000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4453000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1516000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1704000
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2569000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2672000
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
765000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2108000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2217000
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
741000
CY2019Q3 us-gaap Assets
Assets
565193000
CY2018Q4 us-gaap Assets
Assets
443166000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
79214000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
92534000
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
305000
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
1633000
CY2018Q2 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
19835000
CY2018Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
-525000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21933000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23368000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32241000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27856000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23368000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27856000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10308000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4488000
CY2018Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.23
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.69
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.84
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14899233
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14988894
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
150000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
149000
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
0
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
2870000
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
6000000
usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-7929000
CY2018Q3 usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-6402000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
us-gaap Costs And Expenses
CostsAndExpenses
274340000
us-gaap Costs And Expenses
CostsAndExpenses
260118000
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
87046000
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
89879000
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.13
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
43903000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3680000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3099000
CY2019Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
0
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2159000
CY2018Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
9012000
CY2019Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
10336000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7377000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7335000
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3832000
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10723000
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8746000
CY2018Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2918000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.90
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.66
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.88
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21726000
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21089000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
146000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
56467000
CY2019Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
54464000
CY2018Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
52611000
CY2018 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
0
us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
7325000
CY2018 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
19778000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
30293000
CY2019Q3 us-gaap Goodwill
Goodwill
316639000
CY2018Q4 us-gaap Goodwill
Goodwill
293525000
CY2017Q4 us-gaap Goodwill
Goodwill
271338000
CY2018 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
2409000
us-gaap Gross Profit
GrossProfit
85515000
CY2019Q3 us-gaap Gross Profit
GrossProfit
27372000
CY2018Q3 us-gaap Gross Profit
GrossProfit
26076000
us-gaap Gross Profit
GrossProfit
76444000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14870000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16266000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2991000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8734000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11223000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3197000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8957000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9458000
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
1006000
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
3954000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8171000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1092000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-440000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9742000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2744000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-233000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1988000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-443000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
48828000
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
53385000
us-gaap Interest And Other Income
InterestAndOtherIncome
70000
us-gaap Interest And Other Income
InterestAndOtherIncome
27000
CY2018Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
16000
CY2019Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
7000
us-gaap Interest Expense
InterestExpense
1522000
CY2019Q3 us-gaap Interest Expense
InterestExpense
557000
CY2018Q3 us-gaap Interest Expense
InterestExpense
579000
us-gaap Interest Expense
InterestExpense
1677000
us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
us-gaap Interest Paid Net
InterestPaidNet
1705000
us-gaap Interest Paid Net
InterestPaidNet
1412000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
10407000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
15003000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
9987000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
91500000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
565193000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
62798000
usph Excess Of Purchase Price Of Non Controlling Interest Net Of Tax
ExcessOfPurchasePriceOfNonControllingInterestNetOfTax
100000
usph Number Of Partnership Various Interest Sold By Parent
NumberOfPartnershipVariousInterestSoldByParent
3
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
41946000
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
56010000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7387000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6935000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
21344000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
27372000
CY2018Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
64524000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
191410000
CY2019Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
66748000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
203684000
CY2019Q3 us-gaap Lease Cost
LeaseCost
9045000
us-gaap Lease Cost
LeaseCost
28136000
CY2019Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
31948000
CY2018Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
31712000
CY2019Q3 us-gaap Liabilities
Liabilities
188065000
CY2018Q4 us-gaap Liabilities
Liabilities
92348000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
443166000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
39836000
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
55292000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38402000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
718000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
51000000
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
718000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1434000
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
4292000
CY2018Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
402000
CY2019Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
4292000
CY2019Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
51000000
CY2018Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
38000000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
3894000
CY2018Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1238000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
4063000
CY2019Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1292000
CY2019Q3 us-gaap Minority Interest
MinorityInterest
1842000
CY2018Q4 us-gaap Minority Interest
MinorityInterest
930000
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
104000
CY2018Q3 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
79000
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
272000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
54005000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46464000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31965000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21880000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21817000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10011000
us-gaap Net Income Loss
NetIncomeLoss
32110000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
9047000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
8102000
us-gaap Net Income Loss
NetIncomeLoss
24465000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
10704000
CY2018Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3777000
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4022000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
13134000
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
502000
CY2019Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
41
CY2018 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
5
CY2018Q3 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
4
CY2018Q1 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
2
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y0M7D
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
79793000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
7303000
us-gaap Operating Lease Cost
OperatingLeaseCost
22598000
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16816000
us-gaap Operating Income Loss
OperatingIncomeLoss
52139000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15433000
us-gaap Operating Income Loss
OperatingIncomeLoss
45510000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
25644000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
58921000
us-gaap Operating Lease Payments
OperatingLeasePayments
22579000
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
7187000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
84565000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
128000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
120000
CY2019Q3 us-gaap Other Assets Current
OtherAssetsCurrent
7098000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4353000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1430000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1470000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
829000
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
718000
CY2019Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4413000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6350000
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
0
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
265000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10723000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8746000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
30365000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
16303000
CY2018Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
16367000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
10862000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
10470000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
5700000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
5307000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7428000
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
138000
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
272000
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-42000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-17000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
11601000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
11600000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
79000000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
110000000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
64000
us-gaap Profit Loss
ProfitLoss
45244000
us-gaap Profit Loss
ProfitLoss
35169000
CY2018Q3 us-gaap Profit Loss
ProfitLoss
11879000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
933000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
167396000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
84323000
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
86412000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21372000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20169000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3408000
CY2018Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
890000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3102000
CY2019Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
962000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
104833000
CY2019Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6319000
CY2019Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
139801000
CY2018Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
133943000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1409000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2294000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
97000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
79000000
us-gaap Restructuring Charges
RestructuringCharges
8000
CY2019Q3 us-gaap Restructuring Charges
RestructuringCharges
3000
us-gaap Restructuring Charges
RestructuringCharges
12000
CY2018Q3 us-gaap Restructuring Charges
RestructuringCharges
-22000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
181135000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113122000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
359855000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117251000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
336562000
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10643000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30934000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10556000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
33376000
us-gaap Share Based Compensation
ShareBasedCompensation
4453000
us-gaap Share Based Compensation
ShareBasedCompensation
5262000
CY2019Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
130.55
CY2019Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
265000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12774000
CY2008Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
2250000
CY2009Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1200000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2018Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2009Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
859499
CY2018Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
48000
CY2019Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
-11000
us-gaap Stockholders Equity Other
StockholdersEquityOther
-17000
us-gaap Stockholders Equity Other
StockholdersEquityOther
99000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
215945000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
235485000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
216875000
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
237327000
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
212748000
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
230747000
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
206070000
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
213098000
CY2019Q3 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
1643000
usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
3902000
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2214737
CY2019Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2214737
CY2019Q3 us-gaap Treasury Stock Value
TreasuryStockValue
31628000
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31628000
CY2019Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="color: #000000; font-weight: bold;">Use of Estimates</div><div><br /></div><div style="color: #000000;">In preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, purchase accounting, goodwill impairment, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.</div></div>
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1477000
us-gaap Variable Lease Cost
VariableLeaseCost
4605000
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12685000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12660000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12750000
CY2018Q2 usph Business Acquisition Cost Of Acquired Entity Debt Issued
BusinessAcquisitionCostOfAcquiredEntityDebtIssued
950000
CY2019Q3 usph Business Acquisition Cost Of Acquired Entity Debt Issued
BusinessAcquisitionCostOfAcquiredEntityDebtIssued
283000
CY2018Q3 usph Business Acquisition Cost Of Acquired Entity Debt Issued
BusinessAcquisitionCostOfAcquiredEntityDebtIssued
0
CY2018Q2 usph Business Combination Acquisition Fair Value Of Redeemable Non Controlling Interests
BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
8145000
CY2018Q2 usph Payments To Acquire Businesses Consideration
PaymentsToAcquireBusinessesConsideration
17317000
CY2018Q2 usph Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tradename
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
990000
CY2018Q2 usph Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Referral Relationships
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
2926000
CY2018Q2 usph Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Non Competition Agreements
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
298000
CY2018Q2 usph Business Acquisition Purchase Price Allocation Net Tangible Asset
BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
1413000
usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
4300000
usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
950000
usph Payments To Acquire Redeemable Non Controlling Interest
PaymentsToAcquireRedeemableNonControllingInterest
0
usph Payments To Acquire Redeemable Non Controlling Interest
PaymentsToAcquireRedeemableNonControllingInterest
5699000
usph Gain On Sale Of Partnership Interest Net Of Tax
GainOnSaleOfPartnershipInterestNetOfTax
0
usph Gain On Sale Of Partnership Interest Net Of Tax
GainOnSaleOfPartnershipInterestNetOfTax
5823000
usph Gain On Sale Of Partnership Interest
GainOnSaleOfPartnershipInterest
5823000
usph Gain On Sale Of Partnership Interest
GainOnSaleOfPartnershipInterest
0
CY2019Q3 usph Gain On Sale Of Partnership Interest
GainOnSaleOfPartnershipInterest
0
CY2018Q3 usph Gain On Sale Of Partnership Interest
GainOnSaleOfPartnershipInterest
0
usph Sale Of Noncontrolling Interest Percentage In Partnership One
SaleOfNoncontrollingInterestPercentageInPartnershipOne
0.5
usph Number Of Partnership In Interest Sold By Parent
NumberOfPartnershipInInterestSoldByParent
1
usph Business Acquisition Number Of Installments For Payment Of Purchase Consideration
BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration
2
CY2018Q3 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
1321000
usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
4982000
CY2019Q3 usph Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity
NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
2379000
usph Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity
NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
6802000
usph Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity
NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
8152000
CY2018Q3 usph Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity
NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
2456000
CY2018Q3 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
21654000
usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
65598000
usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
67236000
CY2019Q3 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
22166000
usph Percentage Of General Partnership Interest Owned
PercentageOfGeneralPartnershipInterestOwned
0.01
CY2019Q3 usph Number Of Clinics Operated
NumberOfClinicsOperated
574
usph Number Of Third Party Facilities
NumberOfThirdPartyFacilities
26
usph Number Of Regions
NumberOfRegions
6
usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-4753000
CY2018Q3 usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-2279000
usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-2822000
CY2019Q3 usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-242000
usph Effective Income Tax Rate Reconciliation At Federal And State Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate
0.2625
usph Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans
TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
373000
CY2018Q3 usph Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans
TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
0
usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-18105000
CY2019Q3 usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-922000
usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-10752000
CY2018Q3 usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-8680000
CY2018Q3 usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
1701000
usph Purchase Of Partnership Interests Redeemable Non Controlling Interests
PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
298000
usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
11113000
usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
24180000
CY2019Q3 usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
8367000
CY2019Q3 usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-679000
usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-13353000
usph Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans
TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
636000
usph Excess Of Purchase Price Of Non Controlling Interest
ExcessOfPurchasePriceOfNonControllingInterest
400000
usph Number Of Partnership In Which Interest Acquired
NumberOfPartnershipInWhichInterestAcquired
7
usph Combined Physical Therapy Speech Language Pathology Expenses
CombinedPhysicalTherapySpeechLanguagePathologyExpenses
3700
usph Period Of Federal Debt Ceiling In Connection With Deficit Reductions
PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions
P10Y
usph Reduction In Combined Physical Therapy Speech Language Pathology Expenses
ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses
3000
usph Additional Estimated Repurchase Of Common Stock
AdditionalEstimatedRepurchaseOfCommonStock
114899
usph Reduction In Medicare Spending Percentage
ReductionInMedicareSpendingPercentage
0.02
usph Percentage Of Practice Expense Component Of Relative Value Unit
PercentageOfPracticeExpenseComponentOfRelativeValueUnit
1
usph Net Revenue From Medicare
NetRevenueFromMedicare
76600000
usph Net Revenue From Medicare
NetRevenueFromMedicare
88800000
usph Amount Of Reductions In Federal Spending
AmountOfReductionsInFederalSpending
1200000000000
usph Percentage Reduction For Service In Office Or Other Non Institutional Settings
PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings
0.5
usph Percentage Of Payment For Outpatient Therapy Services
PercentageOfPaymentForOutpatientTherapyServices
0.85
CY2018Q1 usph Expected Reduction In Medicare Spending Percentage
ExpectedReductionInMedicareSpendingPercentage
0.02
CY2013Q2 usph Expected Reduction In Medicare Spending Percentage
ExpectedReductionInMedicareSpendingPercentage
0.02
CY2015Q4 usph Expected Reduction In Medicare Spending Percentage
ExpectedReductionInMedicareSpendingPercentage
0.02
usph Maximum Contractual Allowance Reserve Estimate
MaximumContractualAllowanceReserveEstimate
0.01
usph Difference Between Actual Aggregate Contractual Reserve Percentages As Compared To Estimated Contractual Allowance Reserve Percentage
DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage
0.01
usph Difference Between Net Revenues And Corresponding Cash Collections Reflected Percentage Of Net Revenues
DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues
0.01
CY2019Q3 usph Patients And Payors Related Liability
PatientsAndPayorsRelatedLiability
5075000
CY2018Q4 usph Patients And Payors Related Liability
PatientsAndPayorsRelatedLiability
7293000

Files In Submission

Name View Source Status
0001140361-19-020161-index-headers.html Edgar Link pending
0001140361-19-020161-index.html Edgar Link pending
0001140361-19-020161.txt Edgar Link pending
0001140361-19-020161-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex31_3.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usph-20190930.xml Edgar Link completed
usph-20190930.xsd Edgar Link pending
usph-20190930_cal.xml Edgar Link unprocessable
usph-20190930_def.xml Edgar Link unprocessable
usph-20190930_lab.xml Edgar Link unprocessable
usph-20190930_pre.xml Edgar Link unprocessable